Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins

Metabolism

Volumn 28, Issue 3, 1979, Pages 221-229

  Witztum, Joseph L ^a   Schonfeld, Gustav ^a   Weidman, Stuart W ^a   Giese, William E ^a   Dillingham, Mary Ann ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; BILE; BLOOD AND HEMOPOIETIC SYSTEM; HUMAN CELL; LIVER; MAJOR CLINICAL STUDY; THERAPY;

ADULT; APOLIPOPROTEINS; BILE; BODY WEIGHT; COLESTIPOL; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POLYAMINES;

EID: 0018763903     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(79)90067-2     Document Type: Article

References (44)

1. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham study
2. Drug treatment of hyperlipidemia
3. The effects of colestipol on the metabolism of very low density lipoproteins in man
4. Familial hypercholesterolemia: A genetic defect in the low-density lipoprotein receptor
5. HDL cholesterol and other lipids in coronary heart disease—cooperative lipoprotein phenotyping study
6. Plasma high-density lipoprotein concentration and development of ischaemic heart disease
7. Cholestyramine in Type II hyperlipoproteinemia a double-blind trial
8. Colestipol and cholestyramine resin: Comparative effects in familial type II hyperlipoproteinemia
9. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin colestipol
10. The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein
11. Prevalence of serum lipid abnormalities in chronic hemodialysis
12. Lipoprotein lipid alterations with cholestyramine administration
13. Differences among hyperlipoproteinemic subjects in the response of lipoprotein lipids to resin therapy
14. Changes in plasma triglyceride metabolism during withdrawal of bile
15. The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay
16. Apolipoprotein A-II content of human plasma high density lipoproteins measured by radioimmunoassay
17. Assay of total plasma apolipoprotein B concentration in human subjects
18. Dietary and drug treatment of primary hyperlipoproteinemia
19. Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins
20. Metabolic relationships among the plasma lipoproteins—reciprocal changes in the concentrations of very low and low density lipoproteins in man
21. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men
22. Ischemic heart disease in young adults. Metabolic and angiographic diagnosis and the prevalence of type IV hyperlipoproteinemia
23. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol (Stockholm Prospective Study)
24. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction
25. Lipoprotein uptake by cultured human arterial smooth muscle cells
26. Swine aortic smooth muscle in tissue culture. Some effects of purified swine lipoproteins on cell growth and morphology
27. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia
28. Type IV hyperlipoproteinemia: One theory of atherogenesis
29. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins
30. High density lipoprotein as a protective factor against coronary heart disease
31. Hyperlipidemia and atherosclerosis
32. The low density lipoprotein pathway and its relation to atherosclerosis
33. High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in culture
34. Interaction between high density and low density lipoproteins during uptake and degradation by cultured human fibroblasts
35. Characterization of plasma low density lipoproteins of nonhuman primates fed dietary cholesterol
36. The influence of lipoprotein composition on binding, uptake and degradation of different lipoprotein fractions by cultured human arterial smooth muscle cells
37. Influence of lipoproteins from normal and hypercholesterolemic rhesus monkeys on cholesterol esterification and accumulation in arterial smooth muscle cells in culture
38. The transport of triglyceride in the high-density lipoproteins of human plasma
39. High density lipoprotein metabolism in man
40. The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay
41. Differential increases in plasma high density lipoprotein subfractions and apolipoproteins (Apo-LP) in runners
42. A comparative study on the removal of cellular lipids from Landschutz ascites cells by human plasma apolipoproteins